
News|Articles|January 10, 2005
New Product Newswire
Reliant Pharmaceutical, Liberty Corner, N.J., (908) 580-1200, has gained approval for a new lipid-lowering agent. Antara (fenofibrate) Capsules are indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and ApoB and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Hormone Replacement Therapy May Lower Dementia Risk in Postmenopausal Women
3
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
4
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
5







































